Skip to main content

Ganymede Bio and Kytopen to bring cloud-native structured data to gene-modified cell therapy

Laboratory automation, biotechnology

Credit: motorolka/Shutterstock

Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the development and commercialisation of non-viral transfection tools for genome engineering, today announced a partnership to bring the power of cloud native, structured data to Kytopen’s Flowfect platforms. Under this collaboration, the Kytopen transfection systems will integrate Ganymede’s Lab-as-Code platform for:

Register for FREE to keep reading

Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:

  • Insights into HPC, AI, lab informatics & data
  • Curated content for life sciences, engineering & academia
  • Access to Breakthroughs: real-world computing success
  • Free reports & panels, including the Lab Informatics Guide
  • White Papers & software updates for smarter research

Sign up now

Already a member? Log in here

Your data is protected under our privacy policy.

Scientific Computing World covers

Media Partners